Division of Rheumatology and Clinical Immunology
Department of Medicine
Toggle navigation
COLLEGE OF
MEDICINE
Division Home
About Us
Education
Fellowship
Research
Patient Care + Clinical Services
Directory
News + Events
News
Events
CONTACT US
Division News
Gender Equity Event Features Talk on Dismantling Dominant Culture, Celebrates Awardees
The Office of Diversity, Equity and Inclusion at the Larner College of Medicine at the University of Vermont hosted the fourth annual Celebration of Gender Equity in Medicine and Science on March 2, 2023.
Looking at the Future of Cardiovascular Health through the Lens of Early-Career Investigators
The University of Vermont’s Larner College of Medicine features some of the world’s foremost cardiovascular researchers, experts in cardiovascular disease risk factors, thrombosis, atherosclerosis, stroke, and heart failure. the science shared by early-career investigators at the Cardiovascular Research Institute of Vermont’s fourth annual Viridis Montis Challenge, it was apparent that the institution’s reputation and legacy in the field of cardiovascular research will continue to have a global impact.
UVM Cancer Center to Offer Innovative New Cancer Treatment
The University of Vermont Cancer Center will offer a novel, highly effective form of cancer treatment called CAR T-cell therapy, and is expected to begin treating patients in late. The Cancer Center will be the only healthcare institution in Vermont and northern New York to provide the treatment.
Study Shows Speeding Up Heart Rate Helps Heart Failure Patients with Stiff Hearts
A new study published in JAMA Cardiology by UVM cardiovascular medicine fellow Margaret Infeld, M.D., M.S., and colleagues found evidence that by implementing a tailored acceleration of heart rates, they could reduce congestion and improve the circulation of blood in heart failure patients with "stiff" hearts.
Holcombe Named Associate Dean for Cancer Programs at UVM Larner College of Medicine
Randall F. Holcombe, M.D., M.B.A., director of the UVM Cancer Center and chief of the Division of Hematology and Oncology in the Department of Medicine, has been appointed as associate dean for cancer programs at the UVM Larner College of Medicine.
Khadanga Highlights Benefits of High-Intensity Interval Training in Cardiac Rehab for Women
Sherrie Khadanga, M.D., M.S., assistant professor of medicine at UVM's Larner College of Medicine and assistant director of cardiac rehabilitation at the UVM Medical Center, was recently featured in a UVM Health Network HealthSource blog post titled "Women Find Strength with Cardiac Rehab" that focused on how High-Intensity Interval Training (HIIT) exercise can help women's recovery after a cardiac event.
Cushman Interview on Pre- and Post-Pandemic Racial Disparities in Pulmonary Embolism Treatment in The American Journal of Managed Care
(FEBRUARY 11, 2023) Mary Cushman, M.D., M.Sc., professor of medicine and director of the thrombosis and hemostasis program at the UVM Medical Center, recently spoke with The American Journal of Managed Care about racial trends in pulmonary embolism treatment and potential improvements compared with pre-pandemic trends.
Read full story
at
The American Journal of Managed Care
Health IT Analytics Highlights Cardiac Catheterization Study by Solomon & Colleagues
(FEBRUARY 8, 2023) A randomized trial conducted by nephrologist Richard Solomon, M.D., professor of medicine, and colleagues found that a machine-learning intervention provided a higher level of safety during cardiac catheterization, lowering the chances of acute kidney injury (AKI), according to Health IT Analytics.
Read full story
at
Health IT Analytics
HealthDay News Reports Findings of Heart Failure Study by Infeld, Meyer & Colleagues
(FEBRUARY 7, 2023) Results of a study by Margaret Infeld, M.D., clinical cardiac electrophysiology fellow and clinical instructor in the Department of Medicine; cardiologist Markus Meyer, M.D., Ph.D., adjunct associate professor of medicine; and colleagues support heart rate modulation as a therapeutic intervention in HFpEF, according to HealthDay News.
Read full story
at
HealthDay News
CVRI 2023 Viridis Montis Challenge Highlights Early-Career Researchers
The Cardiovascular Research Institute of Vermont held its 4th Annual Viridis Montis Early Career Investigator Challenge on February 1, 2023, and Toishi Sharma, MBBS, cardiovascular disease fellow in the Department of Medicine, was selected as the winner.
Annie Lab Notes Gilman Debunking of Misleading Face Mask Tweet
(JANUARY 25, 2023) In an article published by the Annie Lab newsroom, Gilman Allen, M.D., professor of medicine, disputed a claim in a January 2023 Twitter video highlighting findings from a “brand-new” Japanese study demonstrating that “masking breeds dangerous bacteria and fungi” and therefore justifies ending mandatory mask wearing.
Read full story
at
Annie Lab Newsroom
Kaminsky Quoted in Seven Days Story on Hyperbaric Oxygen Therapy for Long COVID
(JANUARY 18, 2023) David Kaminsky, M.D., professor of medicine, a pulmonologist and critical care physician who routinely sees patients with long COVID symptoms, was quoted in a Seven Days story about the use of hyperbaric oxygen therapy (HBOT) for patients suffering from so-called long COVID.
Read full story
at
Seven Days
Renal & Urology News Reports on Cheung ‘Stroke-Belt’ Study
(JANUARY 17, 2023) A recent study by Katharine L. Cheung, M.D., Ph.D., assistant professor of medicine, and colleagues shows that residence in the so-called stroke belt of the southeastern United States is an independent risk factor for incident chronic kidney disease (CKD), Renal & Urology News reported.
Read full story
at
Renal & Urology News
HealthDay Notes Pandemic-Related Pediatric Firearm Injuries Study by Keller & Colleagues
(JANUARY 16, 2023) Martin Keller, M.D., associate professor of pediatric surgery, is a co-author of a study that found increased pediatric firearm injury and death rates tied to the COVID pandemic, HealthDay News reported.
Read full story
at
HealthDay News
Cushman and Colleagues' Research on Inequities in Health Care Access and Delivery in ASCO Post Article
(DECEMBER 25, 2022) Research by Mary Cushman, M.D., M.Sc., professor of medicine, and colleagues found inequities in treatments and outcomes for pulmonary embolism, The ASCO Post reports.
Read full story
at
The ASCO Post
Cushman and Colleagues Find Social Disparities in Treatments and Outcomes for Pulmonary Embolism
Racial minorities and people with lower incomes or who are insured by Medicare or Medicaid are significantly less likely to receive the most advanced therapies and more likely to die after suffering a pulmonary embolism, according to a new analysis conducted by University of Vermont Professor of Medicine Mary Cushman, M.D., M.Sc., and colleagues.
Cushman Study Links Low Socioeconomic Status with Greater In-Hospital Mortality, Pharmacy Times Reports
(DECEMBER 10, 2022) Trial investigator Mary Cushman, M.D., professor of medicine, presented study findings on social determinants of health [SDOH] and pulmonary embolism treatment and mortality at the American Society of Hematology Annual Meeting, Pharmacy Times reported.
Read full story
at
Pharmacy Times
HealthDay News Reports on Zakai Study of Coronary Heart Disease Risk in White vs. Black Adults
(DECEMBER 2, 2022) Research by Professor of Medicine Neil A. Zakai, M.D., and colleagues shows that increased coronary heart disease risk in White but not Black adults is associated with lower levels of high-density lipoprotein cholesterol, according to HealthDay News.
Read full story
at
HealthDay News
BIDMC Highlights DASH Diet Study Co-authored by Plante
(NOVEMBER 29, 2022) Assistant Professor of Medicine Timothy Plante, M.D., is a co-author of a new study comparing the effects of three different eating patterns on cardiovascular disease, according to Beth Israel Deaconess Medical Center (BIDMC) News.
Read full story
at
Beth Israel Deaconess Medical Center News
HealthDay Reports on Heart Disease Study by Zakai and Colleagues
(NOVEMBER 22, 2022) A study by Professor of Medicine Neil A. Zakai, M.D., Professor of Medicine Mary Cushman, M.D., and colleagues found that lower levels of high-density lipoprotein cholesterol (HDL-C) are associated with increased coronary heart disease (CHD) risk in White but not Black adults, and higher levels of HDL-C are not protective for either group, HealthDay News reported.
Read full story
at
HealthDay News
1
(current)
2
3
4
5
6
7
8
9
10
»